Clinical Trials Directory

Trials / Conditions / Unresectable Cholangiocarcinoma

Unresectable Cholangiocarcinoma

7 registered clinical trials studyying Unresectable Cholangiocarcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
TerminatedGemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Chola
NCT04088188
Academic and Community Cancer Research UnitedPhase 1
RecruitingLiver Transplant Combined With Neoadjuvant Chemo-radiotherapy in the Treatment of Unresectable Hilar Cholangio
NCT04378023
Hospital Vall d'Hebron—
Active Not RecruitingTesting the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver
NCT04175912
National Cancer Institute (NCI)Phase 2
TerminatedA Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic C
NCT03656536
Incyte CorporationPhase 3
CompletedAtezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be
NCT03201458
National Cancer Institute (NCI)Phase 2
CompletedA Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable
NCT03250273
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
UnknownPhotodynamic Therapy (PDT) Cholangiocarcinoma Registry
NCT01524146
Weill Medical College of Cornell University—